| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 183 |
| 1 | IPILIMUMAB | 131 |
| 2 | CARBOPLATIN | 88 |
| 3 | PACLITAXEL | 55 |
| 4 | CYCLOPHOSPHAMIDE | 28 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 28 |
| 7 | DOXORUBICIN | 20 |
| 8 | DURVALUMAB | 19 |
| 9 | PANTOPRAZOLE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IPILIMUMAB | 131 | 0.0030 |
| 1 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 2 | NIVOLUMAB | 183 | 0.0019 |
| 3 | EPIRUBICIN HYDROCHLORIDE | 6 | 0.0009 |
| 4 | TREMELIMUMAB | 4 | 0.0009 |
| 5 | DURVALUMAB | 19 | 0.0009 |
| 6 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 7 | IDECABTAGENE VICLEUCEL | 1 | 0.0008 |
| 8 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 9 | CARBOPLATIN | 88 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 135 | 0.0028 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 184 | 0.0019 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 19 | 0.0009 |
| 4 | Platinum-based Drug [EPC] | 113 | 0.0004 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 4 | 0.0004 |
| 6 | Polyene Antifungal [EPC] | 16 | 0.0004 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 8 | Microtubule Inhibitor [EPC] | 55 | 0.0003 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 5 | 0.0002 |